Single Bolus Non-immunogenic Staphylokinase in Patients With Acute Ischemic Stroke Within 4.5-24 Hours of Symptom Onset

​ Conditions: Ischemic Stroke, Acute

Interventions: Drug: non-immunogenic staphylokinase; Drug: Placebo

Sponsors: Supergene, LLC

Not yet recruiting Conditions: Ischemic Stroke, Acute
Interventions: Drug: non-immunogenic staphylokinase; Drug: Placebo
Sponsors: Supergene, LLC
Not yet recruiting